Pazopanib, a Multikinase Angiogenesis Inhibitor, in Patients With Relapsed or Refractory Advanced Soft Tissue Sarcoma: A Phase II Study From the European Organisation for Research and Treatment of Cancer–Soft Tissue and Bone Sarcoma Group (EORTC Study 62043)

Stefan Sleijfer, Isabelle Ray‐Coquard, Zsuzsa Pápai, +10

Journal of Clinical Oncology

OncologyAngiogenesisBone Sarcoma GroupSoft Tissue SarcomaPharmacology +12

Phase III Trial of Two Investigational Schedules of Ifosfamide Compared With Standard-Dose Doxorubicin in Advanced or Metastatic Soft Tissue Sarcoma: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study

Paul Lorigan, Jaap Verweij, Zsuzsa Pápai, +8

Journal of Clinical Oncology

Outcome of uterine sarcoma patients treated with pazopanib: A retrospective analysis based on two European Organisation for Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group (STBSG) clinical trials 62043 and 62072

Charlotte Benson, Isabelle Ray‐Coquard, Stefan Sleijfer, +12

Gynecologic Oncology

Surgical OncologyUterine FibroidsBone Sarcoma GroupTumoral PathologyUterine Sarcoma Patients +9

Diagnosis of soft tissue tumors by fine‐needle aspiration with combined cytopathology and ancillary techniques

Zoltàn Sápi, Imre Antal, Zsuzsa Pápai, +5

Diagnostic Cytopathology

Ancillary TechniquesDiagnosisPathologyDermatologySoft Tissue Tumors +14

Hypertension (HTN) as a potential biomarker of efficacy in pazopanib-treated patients with advanced non-adipocytic soft tissue sarcoma. A retrospective study based on European Organisation for Research and Treatment of Cancer (EORTC) 62043 and 62072 trials

Florence Duffaud, Stefan Sleijfer, Saskia Litière, +10

European Journal of Cancer

Retrospective StudyHypertensionSurgical OncologyOncologyAntihypertensive Therapy +6

Phase II study of pazopanib (GW786034) in patients (pts) with relapsed or refractory soft tissue sarcoma (STS): EORTC 62043

Stefan Sleijfer, Zsuzsa Pápai, Axel Le Cesne, +7

Journal of Clinical Oncology

Surgical OncologyCancer TherapeuticsCreatinine ElevationsMalignant DiseaseMedicine +12

P53 overexpression as an indicator of overall survival and response to treatment in osteosarcomas

Zsuzsa Pápai, Christina N. FÉja, E. Hanna, +2

Pathology & Oncology Research

Tumor BiologyOverall SurvivalMalignant DiseaseMedicinePathology +5

Allelic losses from chromosome 17 in human osteosarcomas

Marianna Sztán, Zsuzsa Pápai, Miklós Szendrői, +2

Pathology & Oncology Research

SclerostinPathologyChromosome 17MedicineMalignant Disease +1

Her-2 oncogene amplification, chromosome 17 and DNA ploidy status in synovial sarcoma

Zoltàn Sápi, Zsuzsa Pápai, Anett Hruska, +3

Pathology & Oncology Research

Somatic VariantDna Ploidy StatusCytogeneticsPathologyChromosome 17 +5